By Kate Kelland LONDON (Reuters) – Scientists studying the effects of the potentially game-changing gene editing tool CRISPR/Cas9 have found it can cause unexpected genetic damage which could lead to dangerous changes in...
Read More(Reuters) – Indivior Plc’s shares jumped more than 33 percent on Monday after a U.S. court blocked a rival from selling a cheaper copycat of the British drugmaker’s bestselling opioid addiction treatment. The...
Read More
(Reuters) – The Iowa and Illinois health departments said on Thursday that they were...
Read MoreSHANGHAI (Reuters) – China’s new medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of cancer drugs in a bid to cut the financial burden on...
Read More(Reuters) – A U.S. court has granted Indivior a preliminary injunction blocking India’s Dr. Reddy’s Laboratories from selling cut-price versions of the British drugmaker’s best-selling opioid addiction...
Read MoreBy Tina Bellon NEW YORK (Reuters) – Johnson & Johnson has vowed to appeal a $4.7 billion verdict awarded to 22 women who claim asbestos-contaminated talc in the company’s products gave them ovarian cancer by...
Read MoreBy Will Boggs MD NEW YORK (Reuters Health) – There is a new epidemic of hepatitis C, HIV, and other infections within the opioid abuse epidemic, according to participants in a National Academies of Sciences, Engineering,...
Read MoreBy Carolyn Crist (Reuters Health) – Changing the criminal penalties for drug possession could reduce racial and ethnic disparities in the criminal justice system and indirectly reduce health disparities as well,...
Read MoreBy Jan Wolfe (Reuters) – A U.S. appeals court on Friday ruled invalid patents owned by Jazz Pharmaceuticals PLC covering its narcolepsy drug Xyrem, giving Amneal Pharmaceuticals Inc a boost in its effort to launch a...
Read MoreBy Linda Carroll (Reuters Health) – Today’s moms-to-be are more likely than women from their mothers’ generation to become depressed while pregnant, a study suggests. Stresses of the modern world may be driving...
Read MoreBy Shereen Lehman (Reuters Health) – Knowing more about how and when pain starts diminishing after surgery can help doctors and patients understand what’s normal and when to expect a full recovery, suggests a small...
Read More
By Tina Bellon (Reuters) – A Missouri jury on Thursday ordered Johnson & Johnson...
Read More
(Reuters) – The U.S. Food & Drug Administration said on Thursday recalled Kellogg Co...
Read More
(Reuters) – The Centers for Medicare & Medicaid Services on Thursday proposed a change...
Read MoreBy Lisa Rapaport (Reuters Health) – Athletes who drink chocolate milk during exercise or after a hard workout may recover just as quickly as they would with sports drinks, a research review suggests. What people eat and...
Read MoreBy Carolyn Crist (Reuters Health) – Employers and workers need to be aware that heat stress can happen well before temperatures reach official limits for workplace safety, a U.S. study suggests. The “heat...
Read More
LONDON (Reuters) – Britain’s Prince Harry and music star Elton John are joining forces...
Read More
By Lisa Rapaport (Reuters Health) – Advanced imaging tests for many common health problems...
Read MoreBy Lisa Rapaport (Reuters Health) – People are more likely to be hospitalized for respiratory disorders during the annual haze season in Southeast Asia, when densely polluted air hovers over the region, than at other times...
Read MoreGENEVA (Reuters) – The World Health Organization (WHO) called on Thursday for access to 210,000 displaced people who have fled fighting in southern Syria and are in urgent need of medicines and health services, including...
Read More
